Form D · Pharmaceuticals
TETRALOGIC PHARMACEUTICALS CORP
Malvern, PA · CIK 0001361248
Offering snapshot reported Dec 13, 2012 · SEC filing
- Reported sold
- $5M Offering amount: $10M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 29, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 13, 2012 | Initial | $5,000,000 | No comparison | 21 | SEC filing |
| May 31, 2011 | Initial | $5,999,734 | No comparison | 2 | SEC filing |
| Aug 10, 2010 | Initial | $12,496,000 | No comparison | 10 | SEC filing |
| Mar 24, 2010 | Amendment | $2,000,000 | $0vs Mar 9, 2010 | 13 | SEC filing |
| Mar 24, 2010 | Initial | $2,400,000 | No comparison | 13 | SEC filing |
| Mar 9, 2010 | Initial | $2,000,000 | No comparison | 13 | SEC filing |
| Apr 6, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-188311
Source: Form D, filed Dec 13, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brenda Gavin | Director |
| John M. Gill | Director, Executive |
| James E. Goldschmidt | Executive |
| Helga Kautsky | Executive |
| Jack Lasersohn | Director |
| Mark A. Mc Kinlay | Executive |
| George Mc Lendon | Director |
| Douglas Onsi | Director |
| Andrew Pecora | Director |
| Douglas Reed | Director |
| Paul Schmitt | Director |
| Michael Steinmetz | Director |
| David E. Weng | Executive |
| Harold Werner | Director |
| James Woody | Director |
| Jim Woody | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
343 Phoenixville Pike
Malvern, PA, 19355
Malvern, PA, 19355